Bioventus Inc (BVS) — Cash Flow-to-Debt Ratio
Bioventus Inc (BVS) has a Cash Flow-to-Debt Ratio of 0.02x as of March 2026, meaning its operating cash flow of $8.93 Million could theoretically repay 0% of its total liabilities ($416.27 Million) in one year. See BVS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bioventus Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Bioventus Inc across 10 annual periods. Also explore Bioventus Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bioventus Inc (2014–2025)
Year-by-year debt coverage analysis for Bioventus Inc. For market capitalisation and broader financial context, see market value of Bioventus Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | $73.98 Million | $455.11 Million | ▲ +127.2% |
| 2024 | 0.07x | $38.80 Million | $542.35 Million | ▲ +175.0% |
| 2023 | 0.03x | $15.34 Million | $589.79 Million | ▲ +284.6% |
| 2022 | -0.01x | $-13.54 Million | $960.43 Million | ▼ -142.4% |
| 2021 | 0.03x | $22.99 Million | $692.07 Million | ▼ -83.8% |
| 2020 | 0.20x | $71.80 Million | $350.31 Million | ▲ +64.5% |
| 2019 | 0.12x | $40.71 Million | $326.79 Million | ▼ -18.0% |
| 2018 | 0.15x | $45.19 Million | $297.46 Million | ▲ +136.9% |
| 2015 | 0.06x | $18.92 Million | $295.01 Million | ▲ +7.4% |
| 2014 | 0.06x | $15.11 Million | $252.93 Million | — |